课题基金 / 基金详情

53rd Annual Thomas L Petty Aspen Lung Conference: Systems Biology of Lung Disease

53rd Annual Thomas L Petty Aspen Lung Conference: Systems Biology of Lung Disease
第 53 届 Thomas L Petty Aspen 肺病年度会议:肺部疾病的系统生物学
批准号:
8005685
负责人:
MARK W GERACI
金额:
$1.5万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2011-06-30

项目摘要

项目成果

MARK W GERACI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The theme of the 53rd Annual Thomas L. Petty Aspen Lung Conference is "Systems Biology of Lung Diseases - Progress in the 'Omics' Era." With an emphasis on integration between basic, translational and clinical sciences, the meeting will focus on the utilization of newer technologies to investigate the pathogenesis, treatments, and outcomes of lung diseases. Anchored by twelve "state-of-the-art" presentations, thematic sessions will address single gene and complex genetic disorders, genomic and proteomic approaches, the epigenome, integrative informatics and personalized medicine. Dean Sheppard, MD, from the University of California San Francisco, will be the Conference Summarizer. The main objectives include 1) provide an international forum for clinicians and researchers to exchange ideas relating to clinical problems and research of the lung; 2) fill a recognized need for participation in a field where knowledge is doubling every five years; 3) provide an opportunity for participants to focus on a single topic exhaustively by review and discussion with nationally and internationally recognized clinicians and researchers; and 4) provide an impetus to further research in pulmonary and critical care medicine. PUBLIC HEALTH RELEVANCE: The theme of the 53rd Annual Thomas L. Petty Aspen Lung Conference is "Systems Biology of Lung Diseases - Progress in the 'Omics' Era." The emphasis will be on the integration between basic, translational and clinical sciences; the meeting will focus on the utilization of newer technologies to investigate the pathogenesis, treatments, and outcomes of lung diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer
  • 批准号:
    8320228
  • 项目类别:
  • 资助金额:
    $60.14万
  • 财政年份:
    2011
  • 负责人:
    MARK W GERACI
  • 依托单位:
Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer
  • 批准号:
    8490706
  • 项目类别:
  • 资助金额:
    $56.42万
  • 财政年份:
    2011
  • 负责人:
    MARK W GERACI
  • 依托单位:
Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer
  • 批准号:
    8097154
  • 项目类别:
  • 资助金额:
    $60.27万
  • 财政年份:
    2011
  • 负责人:
    MARK W GERACI
  • 依托单位:
Lung Genomics Research Consortium
  • 批准号:
    7939886
  • 项目类别:
  • 资助金额:
    $375.97万
  • 财政年份:
    2009
  • 负责人:
    MARK W GERACI
  • 依托单位:
国内基金
海外基金
Handbook of the Mathematics of the Arts and Sciences的中文翻译
  • 批准号:
    12226504
  • 项目类别:
    数学天元基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2022
  • 负责人:
    黄朝凌
  • 依托单位:
ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    35万元
  • 批准年份:
    2020
  • 负责人:
    陈加祥
  • 依托单位:
ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
  • 批准号:
    82060278
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2020
  • 负责人:
    陈加祥
  • 依托单位:
促进肿瘤凋亡的融合蛋白CPP-TRAIL-ARTS C27的制备及机制研究
  • 批准号:
    81372444
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2013
  • 负责人:
    易成
  • 依托单位: